Abstract
Mitochondrial dysfunction has historically been linked to the cessation of cell function and ageing. Downstream effects such as reduced calcium buffering capacity, elevated levels of reactive oxygen species, and alterations in adenosine-5′-triphosphate are linked to a wide variety of pathological diseases. The importance of the mitochondria has increasingly been highlighted due to its potential as a therapeutic target for drug intervention and cell elimination in cancer. In addition, due to its origin, drugs targeting bacteria are required to be thoroughly tested prior to administration to prevent toxicity for the mitochondria. In this chapter, we will discuss a variety of factors that could influence mitochondrial dysfunction and highlight potential solutions to these. A comprehensive understanding regarding the mechanisms underlying mitochondrial dysfunction could aid in developing future therapeutic targets in multiple pathologies such as cancer and liver diseases.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lane N, Martin W. The energetics of genome complexity. Nature. 2010;467(7318):929–34.
Shyh-Chang N, Daley GQ, Cantley LC. Stem cell metabolism in tissue development and aging. Development. 2013;140(12):2535–47.
Sahin E, DePinho RA. Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature. 2010;464(7288):520–8.
Bao L, Diao H, Dong N, Su X, Wang B, Mo Q, Yu H, Wang X, Chen C. Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation. Cell Biol Toxicol. 2016;32(6):469–82.
Fallahian F, Aghaei M, Abdolmohammadi MH, Hamzeloo-Moghadam M. Molecular mechanism of apoptosis induction by Gaillardin, a sesquiterpene lactone, in breast cancer cell lines. Cell Biol Toxicol. 2015;31(6):295–305.
Lippai M, Szatmári Z. Autophagy—from molecular mechanisms to clinical relevance. Cell Biol Toxicol. 2017;33(2):145–68.
Zhou Y, Zhang S, Dai C, Tang S, Yang X, Li D, Zhao K, Xiao X. Quinocetone triggered ER stress-induced autophagy via ATF6/DAPK1-modulated mAtg9a trafficking. Cell Biol Toxicol. 2016;32(2):141–52.
Sidor-Kaczmarek J, Cichorek M, Spodnik JH, Wójcik S, Moryś J. Proteasome inhibitors against amelanotic melanoma. Cell Biol Toxicol. 2017;33:1–17.
Mbah NE, Overmeyer JH, Maltese WA. Disruption of endolysosomal trafficking pathways in glioma cells by methuosis-inducing indole-based chalcones. Cell Biol Toxicol. 2017;33(3):263–82.
Soltani B, Ghaemi N, Sadeghizadeh M, Najafi F. Curcumin confers protection to irradiated THP-1 cells while its nanoformulation sensitizes these cells via apoptosis induction. Cell Biol Toxicol. Dec. 2016;32(6):543–61.
Divolis G, Mavroeidi P, Mavrofrydi O, Papazafiri P. Differential effects of calcium on PI3K-Akt and HIF-1α survival pathways. Cell Biol Toxicol. 2016;32(5):437–49.
Chiang H-C, Wang C-H, Yeh S-C, Lin Y-H, Kuo Y-T, Liao C-W, Tsai F-Y, Lin W-Y, Chuang W-H, Tsou T-C. Comparative microarray analyses of mono(2-ethylhexyl)phthalate impacts on fat cell bioenergetics and adipokine network. Cell Biol Toxicol. 2017:1–16.
Seo JB, Jung S-R, Hille B, Koh D-S. Extracellular ATP protects pancreatic duct epithelial cells from alcohol-induced damage through P2Y1 receptor-cAMP signal pathway. Cell Biol Toxicol. Jun. 2016;32(3):229–47.
Zerin T, Kim J-S, Gil H-W, Song H-Y, Hong S-Y. Effects of formaldehyde on mitochondrial dysfunction and apoptosis in SK-N-SH neuroblastoma cells. Cell Biol Toxicol. Dec. 2015;31(6):261–72.
Cristofori P, Sauer AV, Trevisan A. Three common pathways of nephrotoxicity induced by halogenated alkenes. Cell Biol Toxicol. Feb. 2015;31(1):1–13.
Ganta KK, Mandal A, Chaubey B. Depolarization of mitochondrial membrane potential is the initial event in non-nucleoside reverse transcriptase inhibitor efavirenz induced cytotoxicity. Cell Biol Toxicol. Feb. 2017;33(1):69–82.
Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly-Y M, Gidlöf S, Oldfors A, Wibom R, Törnell J, Jacobs HT, Larsson N-G. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature. 2004;429(6990):417–23.
Bonawitz ND, Chatenay-Lapointe M, Pan Y, Shadel GS. Reduced TOR signaling extends chronological life span via increased respiration and upregulation of mitochondrial gene expression. Cell Metab. 2007;5(4):265–77.
Kang S-J, Lee H-M, Park Y-I, Yi H, Lee H, So B, Song J-Y, Kang H-G. Chemically induced hepatotoxicity in human stem cell-induced hepatocytes compared with primary hepatocytes and HepG2. Cell Biol Toxicol. 2016;32(5):403–17.
Zhu L, Hou Y, Zhao M, Yang M, Fu X, Sun J, Fu X, Shao L, Zhang H, Fan C, Gao H, Sun B. Caudatin induces caspase-dependent apoptosis in human glioma cells with involvement of mitochondrial dysfunction and reactive oxygen species generation. Cell Biol Toxicol. 2016;32(4):333–45.
Arumugam P, Samson A, Ki J, Song JM. Knockdown of clusterin alters mitochondrial dynamics, facilitates necrosis in camptothecin-induced cancer stem cells. Cell Biol Toxicol. 2017;33(3):307–21.
Medvedev R, Hildt E, Ploen D. Look who’s talking—the crosstalk between oxidative stress and autophagy supports exosomal-dependent release of HCV particles. Cell Biol Toxicol. 2017;33(3):211–31.
Opperman CM, Sishi BJN. Tumor necrosis factor alpha stimulates p62 accumulation and enhances proteasome activity independently of ROS. Cell Biol Toxicol. 2015;31(2):83–94.
Xu M, Wang X. Critical roles of mucin-1 in sensitivity of lung cancer cells to tumor necrosis factor-alpha and dexamethasone. Cell Biol Toxicol. 2017;33(4):361–71.
Acknowledgements
The work was supported by Zhongshan Distinguished Professor Grant (XDW), National Nature Science Foundation of China (91230204, 81270099, 81320108001, 81270131, 81300010), Shanghai Committee of Science and Technology (12JC1402200, 12431900207, 11410708600, 14431905100), Operation funding of Shanghai Institute of Clinical Bioinformatics, Ministry of Education for Academic Special Science and Research Foundation for PhD Education (20130071110043), and National Key Research and Development Program (2016YFC0902400, 2017YFSF090207).
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 The Editor(s) (if applicable) and The Author(s) 2018
About this chapter
Cite this chapter
Wang, W., Hou, J., Zhu, Z., Fang, H. (2017). Is Mitochondrial Cell Fragility a Cell Weakness?. In: Sun, H., Wang, X. (eds) Mitochondrial DNA and Diseases. Advances in Experimental Medicine and Biology, vol 1038. Springer, Singapore. https://doi.org/10.1007/978-981-10-6674-0_8
Download citation
DOI: https://doi.org/10.1007/978-981-10-6674-0_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-6673-3
Online ISBN: 978-981-10-6674-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)